RAC 2.20% $1.78 race oncology ltd

General Comments / Chat, page-3398

  1. 2,932 Posts.
    lightbulb Created with Sketch. 1304
    This was in the previous 4C -

    "Pillar 2 – initiation of the Australian-based, late-stage metastatic study and a decision on
    the anthracycline naïve patient clinical trial opportunity"

    So it depends on how you read the last two updates together..

    Again there is plenty of value to come elsewhere!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.